Date of report : 2021-06-11
Optic Nerve Atrophy
Major Points and Findings:
Objective: The review aimed to provide an update on the potential of cell therapies to restore or replace damaged and/or lost cells in retinal degenerative and
Stem Cell Medical Reports for: Optic Nerve Atrophy
Date of report : 2015-05-14
Optic Nerve Atrophy
Abstract:
Stem cell therapies are being researched extensively for treating degenerative eye diseases.
These therapies aim to replace lost neurons, restore neural circuits, or provide paracrine-mediated therapies where stem cell-derived
Date of report : 2019-02-13
Optic Nerve Atrophy
Major Points and Findings:
Introduction and Background:
Degenerative retinal diseases, such as diabetic retinopathy and macular degeneration, are leading causes of blindness in the developed world.
Current therapies can slow
Date of report : 2019-12-05
Optic Nerve Atrophy
Background:
The study reports the results of 6 patients with Dominant Optic Atrophy (DOA) who were treated in the Stem Cell Ophthalmology Treatment Study (SCOTS).
SCOTS/SCOTS 2 is an Institutional
Date of report : 2016-11-26
Optic Nerve Atrophy
The medical report titled "Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials" focuses on the potential of mesenchymal stem cells (MSCs) in treating
Date of report : 2011-09-02
Optic Nerve Atrophy
Major Points:
Epidemiology and Risk Factors: AMD is prevalent among older adults, and risk factors include genetic predispositions, environmental factors like sunlight exposure, and lifestyle choices such as smoking and
Date of report : 2002-11-01
Optic Nerve Atrophy
Objective and Methods:
The study aimed to explore the influence of baseline lesion composition on vision outcomes in patients with AMD treated with verteporfin for subfoveal choroidal neovascularization (CNV). Patients
Date of report : 2012-02-28
Optic Nerve Atrophy
Major Points:
Introduction to AMD: Age-related macular degeneration is a complex condition involving interactions between various biological factors that can lead to choroidal neovascularization (CNV). VEGF plays a crucial role
Date of report : 2003-05-01
Optic Nerve Atrophy
Abstract Summary:
This research is a cross-sectional study that aimed to understand the relationship between the degree of optic nerve pallor, also known as optic atrophy, and visual function. The
Date of report : 2020-07-20
Optic Nerve Atrophy
Major Points and Findings:
Prevalence and Risk Factors:
AMD is most prevalent in persons over 65 in industrialized countries.
The number of people with early-stage AMD in Germany increased
Date of report : 2022-08-08
Optic Nerve Atrophy
Definition
Optic atrophy is the hallmark of damage to the visual pathway, appearing as a pale disc on fundus examination. It is not a disease in itself but indicates damage